Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
4 Patents
#658 in London
#3,872 in United Kingdom
Centauri Therapeutics Limited (gb/gb)
Forward Citations = 1
4 inventors:
Centauri Therapeutics Limited (gb/gb)
Forward Citations = 1
Loading Chart...
Loading Chart...
4 inventors (with patents filed for the assignee):
Melanie Glossop (4 out of 10 patents)
Christine Watson (4 out of 7 patents)
Michael Westby (3 out of 5 patents)
4. Christopher Pickford (1 out of 1 patent)
4 patents:
Company Overview
Centauri Therapeutics is a UK-based biotechnology company focused on developing novel antibacterial therapeutics. Their proprietary Alphamer platform is designed to target and disrupt specific bacterial proteins, offering a new approach to combating antibiotic-resistant infections. Centauri's innovative research aims to address the urgent global health threat posed by multidrug-resistant bacteria.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Centauri Therapeutics Limited (gb/gb). Retrieved from https://idiyas.com/company/centauri-therapeutics-gb-gb
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]